S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
Log in

NASDAQ:AFFX - Affymetrix Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume3.49 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Affymetrix, Inc (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
Current SymbolNASDAQ:AFFX
CUSIP00826T10
Phone+1-408-7315000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive AFFX News and Ratings via Email

Sign-up to receive the latest news and ratings for AFFX and its competitors with MarketBeat's FREE daily newsletter.


Affymetrix (NASDAQ:AFFX) Frequently Asked Questions

What is Affymetrix's stock symbol?

Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."

How were Affymetrix's earnings last quarter?

Affymetrix, Inc. (NASDAQ:AFFX) released its quarterly earnings results on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.11 by $0.02. The scientific and technical instruments company earned $95.60 million during the quarter, compared to the consensus estimate of $93.29 million. During the same quarter in the previous year, the company earned $0.09 EPS. View Affymetrix's Earnings History.

Has Affymetrix been receiving favorable news coverage?

News headlines about AFFX stock have been trending somewhat positive this week, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Affymetrix earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned news headlines about the scientific and technical instruments company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Affymetrix.

Who are some of Affymetrix's key competitors?

What other stocks do shareholders of Affymetrix own?

What is Affymetrix's official website?

The official website for Affymetrix is http://www.affymetrix.com/.

How can I contact Affymetrix?

Affymetrix's mailing address is 3420 Central Expy, SANTA CLARA, CA 95051-0703, United States. The scientific and technical instruments company can be reached via phone at +1-408-7315000.


MarketBeat Community Rating for Affymetrix (NASDAQ AFFX)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  265 (Vote Outperform)
Underperform Votes:  363 (Vote Underperform)
Total Votes:  628
MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe AFFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: What causes a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel